Health Care & Life Sciences » Pharmaceuticals | Otsuka Holdings Co. Ltd.

Otsuka Holdings Co. Ltd. | Cash Flow

Fiscal year is January-December. All values JPY Millions.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
210,225
150,299
116,680
103,712
109,497
Depreciation, Depletion & Amortization
49,745
59,156
59,574
62,235
59,275
Other Funds
4,189
1,587
1,847
7,155
4,873
Funds from Operations
217,846
204,604
138,632
139,314
163,898
Changes in Working Capital
8,615
53,288
3,372
36,482
28,077
Net Operating Cash Flow
226,461
257,892
142,004
102,832
135,821
Capital Expenditures
69,943
75,540
71,587
77,541
Sale of Fixed Assets & Businesses
1,188
1,654
1,703
538
Purchase/Sale of Investments
77,801
25,953
83,109
85,672
Net Investing Cash Flow
108,514
422,587
135,100
40,072
Cash Dividends Paid - Total
32,752
49,180
54,699
54,861
Issuance/Reduction of Debt, Net
103
225,795
36,545
32,516
Net Financing Cash Flow
66,695
175,020
93,094
94,537
Net Change in Cash
60,733
1,529
90,743
33,261
Free Cash Flow
177,684
200,977
97,619
48,679
Net Assets from Acquisitions
95,356
392,434
-
47,100
Other Sources
583
17,778
17,893
-
Change in Capital Stock
29,651
6
2
2
Exchange Rate Effect
9,481
8,796
4,553
1,484
Other Uses
22,787
-
-
1,640

About Otsuka Holdings Co.

View Profile
Address
Shinagawa Grand Central Tower, 12/F
Tokyo Tokyo 108
Japan
Employees -
Website http://www.otsuka.com
Updated 07/08/2019
Otsuka Holdings Co., Ltd. engages in the manufacture and sale of pharmaceuticals and nutritional supplements. It operates through the following businesses: Pharmaceuticals, Nutraceuticals, Consumer Products, and Others. The Pharmaceuticals business manufactures therapeutic drugs and infusions focusing on the central nervous system, oncology, and infectious diseases.